
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Supplements and Featured Publications
almost 27 years ago
Selected Abstractsalmost 27 years ago
CME Quizalmost 27 years ago
Participating Faculty





